Beth Anne Lang

Beth Anne Lang possesses extensive experience in regulatory affairs and pharmacovigilance within the pharmaceutical industry. Currently serving as Senior Vice President, Regulatory Affairs and Pharmacovigilance at Priovant Therapeutics, Lang has held several senior leadership roles at Akari Therapeutics and Enzyvant, focusing on regulatory strategies for biotech products. Previous positions include Vice President and Senior Vice President roles at Takeda, where leadership spanned across marketed products and new developments in cardiovascular and metabolic areas. Lang's career commenced at Abbott Laboratories and TAP Pharmaceuticals, where foundational expertise in regulatory strategy and quality control was developed. An MBA in Leadership from Marquette University and background in Food Science and Microbiology from the University of Illinois underline strong academic credentials.